OSRH
OSR Holdings Inc
NASDAQ: OSRH · HEALTHCARE · BIOTECHNOLOGY
$0.70
+52.80% today
Updated 2026-04-30
Market cap
$23.98M
P/E ratio
—
P/S ratio
8.25x
EPS (TTM)
$-0.92
Dividend yield
—
52W range
$0 – $2
Volume
7.0M
OSR Holdings Inc (OSRH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $3.53M | $2.91M |
| Revenue growth (YoY) | — | — | — | — | — | -17.7% |
| Cost of revenue | — | — | $0.00 | $2.53M | $2.72M | $2.31M |
| Gross profit | — | — | $0.00 | $921414.00 | $811236.00 | $592905.00 |
| Gross margin | — | — | — | — | 23.0% | 20.4% |
| R&D | — | — | $0.00 | $251103.00 | $161155.00 | $318446.00 |
| SG&A | — | $3308.00 | $35388.00 | $1.83M | $2.53M | $9.19M |
| Operating income | $-23810.00 | $-3308.00 | $-35388.00 | $-1.83M | $-11.69M | $-18.34M |
| Operating margin | — | — | — | — | -331.2% | -631.0% |
| EBITDA | $-23810.00 | $233250.00 | $193097.00 | $3.72M | $-2.15M | $-19.08M |
| EBITDA margin | — | — | — | — | -60.9% | -656.5% |
| EBIT | $-230107.00 | $-3308.00 | $-35388.00 | $944591.00 | $-11.84M | $-28.38M |
| Interest expense | — | — | $14224.00 | $0.00 | $43011.00 | $506196.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-23812.00 | $-3308.00 | $-35388.00 | $403780.00 | $-10.33M | $-18.01M |
| Net income growth (YoY) | — | +86.1% | -969.8% | +1241.0% | -2658.1% | -74.4% |
| Profit margin | — | — | — | — | -292.6% | -619.8% |